Quick Answer
Biohaven Ltd. reported Diluted EPS of $6.86 per share (loss) for fiscal year 2025.
Biohaven Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$6.86 | +26.1% |
| 2024 | -$9.28 | -62.0% |
| 2023 | -$5.73 | +55.1% |
| 2022 | -$12.75 | -134.8% |
| 2021 | -$5.43 | -80.4% |
| 2020 | -$3.01 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.64 | +3.5% | +15.5% |
| June 30, 2025 | -$1.94 | +46.7% | +10.6% |
| March 31, 2025 | -$2.17 | +1.4% | -27.6% |
| September 30, 2024 | -$1.70 | -13.3% | +53.3% |
| June 30, 2024 | -$3.64 | -175.8% | -65.5% |
| March 31, 2024 | -$2.20 | -113.6% | -46.7% |
| September 30, 2023 | -$1.50 | +14.3% | -13.6% |
| June 30, 2023 | -$1.32 | +74.4% | -28.2% |
- Biohaven Ltd. showed an increase of +26.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Biohaven Ltd.’s diluted eps has declined by 127.9% (from $3.01 per share (loss) to $6.86 per share (loss)).
- The most recent figure is from Biohaven Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: